Home > Boards > US Listed > Biotechs > Cytokinetics, Inc. (CYTK)

News: $CYTK Cytokinetics Announces Receipt of FDA Feedback

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
 
Followed By 118
Posts 14,866
Boards Moderated 5
Alias Born 06/04/18
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 4:58:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 4:58:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 4:58:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 4:57:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 4:57:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/4/2021 4:57:34 PM
Cytokinetics to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 3/2/2021 4:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/1/2021 5:06:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/1/2021 5:05:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/1/2021 5:02:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/1/2021 6:06:59 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/26/2021 6:25:43 PM
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. - 2/26/2021 4:32:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/26/2021 7:30:58 AM
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day GlobeNewswire Inc. - 2/26/2021 7:30:00 AM
Cytokinetics EPS misses by $0.13, misses on revenue Seeking Alpha - 2/25/2021 4:19:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2021 4:01:19 PM
Cytokinetics Reports Fourth Quarter 2020 Financial Results GlobeNewswire Inc. - 2/25/2021 4:00:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/19/2021 5:03:28 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/19/2021 4:20:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/18/2021 7:30:59 AM
Cytokinetics Names Muna Bhanji to Board of Directors GlobeNewswire Inc. - 2/18/2021 7:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 3:17:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/12/2021 6:39:21 PM
Cytokinetics to Announce Fourth Quarter Results on February 25, 2021 GlobeNewswire Inc. - 2/11/2021 4:00:00 PM
whytestocks   Tuesday, 01/22/19 07:41:50 AM
Re: None
Post # of 1503 
News: $CYTK Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients With SMA

SOUTH SAN FRANCISCO, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it has received feedback from the U.S. Food and Drug Administration (FDA) that the Six Minute Walk Test (6MWT) is an acceptable primary efficacy endpoint for a poten...

Read the whole news https://marketwirenews.com/news-releases/cytokinetics-announces-receipt-of-fda-feedback-regarding-reldesemtiv-in-patients-with-sma-7414652.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences